Pharmaceuticals Companies By Gross Profit

Gross Profit
Gross ProfitEfficiencyMarket RiskExp Return
1TAK Takeda Pharmaceutical Co
2.44 T
(0.15)
 1.05 
(0.16)
2NVO Novo Nordisk AS
148.51 B
 0.13 
 2.01 
 0.27 
3RDY Dr Reddys Laboratories
113.84 B
 0.09 
 1.21 
 0.11 
4PFE Pfizer Inc
66.23 B
(0.08)
 1.44 
(0.11)
5JNJ Johnson Johnson
63.95 B
(0.16)
 0.81 
(0.13)
6MRK Merck Company
42.08 B
 0.12 
 1.14 
 0.14 
7NVS Novartis AG ADR
36.74 B
(0.06)
 1.14 
(0.07)
8BMY Bristol Myers Squibb
36.38 B
(0.08)
 1.65 
(0.14)
9AZN AstraZeneca PLC ADR
35.73 B
 0.15 
 1.42 
 0.21 
10SNY Sanofi ADR
31.7 B
(0.02)
 1.37 
(0.03)
11LLY Eli Lilly and
21.91 B
 0.13 
 1.70 
 0.22 
12GSK GlaxoSmithKline PLC ADR
19.92 B
 0.10 
 1.00 
 0.10 
13VTRS Viatris
7.03 B
(0.01)
 1.71 
(0.01)
14TEVA Teva Pharma Industries
6.97 B
 0.15 
 1.79 
 0.26 
15BHC Bausch Health Companies
5.76 B
 0.04 
 2.46 
 0.10 
16ZTS Zoetis Inc
5.63 B
(0.14)
 2.03 
(0.29)
17OGN Organon Co
3.89 B
 0.07 
 2.66 
 0.18 
18JAZZ Jazz Pharmaceuticals PLC
3.39 B
(0.15)
 1.70 
(0.26)
19ELAN Elanco Animal Health
2.5 B
(0.10)
 1.99 
(0.20)
20PRGO Perrigo Company PLC
1.46 B
 0.00 
 2.62 
(0.01)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments. Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.